Reversal of haloperidol-induced extrapyramidal symptoms by buspirone: a time-related study
Authors:
- Darakhshan Jabeen HaleemDHDarakhshan Jabeen Haleem
- Noreen SamadNSNoreen Samad
- Muhammad Abdul HaleemMHMuhammad Abdul Haleem
- 1 March 2007
- journal article
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 18 (2) , 147-153
Abstract
Effects of coadministration of buspirone were investigated on the time course of haloperidol-induced extrapyramidal symptoms in rats. Rats treated with haloperidol at a dose of 1 mg/kg exhibited impaired motor coordination and a decrease in exploratory activity. Coadministration of buspirone at a dose of 1 mg/kg attenuated haloperidol-induced deficits of motor coordination but no effect was produced on the deficits of exploratory activity, possibly because of a 'floor effect'. Long-term administration of haloperidol (1 mg/kg) twice a day for 5 weeks did not produce tolerance to haloperidol-induced deficits of exploratory activity. The deficits of motor coordination were attenuated after 4-5 weeks of drug administration. Coadministration of buspirone for 3-5 weeks attenuated and reversed haloperidol-induced deficits of exploratory activity. Deficits of motor coordination were smaller in rats cotreated with buspirone after 1 week but not after 2-5 weeks. Administration of haloperidol for 2 weeks elicited vacuous chewing movements with twitching of facial musculature that increased in a time-dependent manner as the treatment continued to 5 weeks. Animals cotreated with buspirone exhibited a gradual reversal of the response during 2-5 weeks of treatment. The mechanism involved in the attenuation/reversal of haloperidol-induced extrapyramidal symptoms by buspirone is discussed. Prior administration of buspirone for 2 weeks may be of help in the improvement of extrapyramidal symptoms induced by antipsychotic drugs.Keywords
This publication has 37 references indexed in Scilit:
- Behavioural effects of chronic haloperidol and risperidone treatment in ratsBehavioural Brain Research, 2006
- Is there a role for 5-HT1A agonists in the treatment of depression?Biological Psychiatry, 2003
- The Current Status of Tardive DyskinesiaAustralian & New Zealand Journal of Psychiatry, 2000
- Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptorsNeuropharmacology, 1996
- Buspirone in Levodopa-Induced DyskinesiasClinical Neuropharmacology, 1994
- Time sampling observation procedure for studying drug effects: Interaction between d-amphetamine and selective dopamine receptor antagonists in the ratPharmacology Biochemistry and Behavior, 1993
- Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesisNeuropharmacology, 1992
- The effect of serotonergic agents on haloperidol-induced catalepsyLife Sciences, 1990
- Serotonin in Involuntary Movement DisordersInternational Journal of Neuroscience, 1988
- Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptorsBiological Psychiatry, 1985